{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:25:36Z","timestamp":1758817536277},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1097\/maj.0b013e31829a348b","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T11:25:10Z","timestamp":1376047510000},"page":"382-386","source":"Crossref","is-referenced-by-count":12,"title":["Decreased Femoral Cartilage Thickness in Patients With Systemic Sclerosis"],"prefix":"10.1016","volume":"347","author":[{"given":"Gamze","family":"Kilic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkan","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozg\u00fcr","family":"Akgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Ozgocmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31829a348b_bb0005","first-page":"961","article-title":"Systemic sclerosis\/scleroderma: a treatable multisystem disease","volume":"78","author":"Hinchcliff","year":"2008","journal-title":"Am Fam Physician"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.berh.2008.01.008","article-title":"Musculoskeletal involvement in systemic sclerosis","volume":"22","author":"Randone","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-857X(03)00017-6","article-title":"Musculoskeletal involvement in scleroderma","volume":"29","author":"Pope","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0738-081X(94)90332-8","article-title":"Joint and periarticular involvement in systemic sclerosis","volume":"12","author":"Schumacher","year":"1994","journal-title":"Clin Dermatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ard.41.2.147","article-title":"The articular manifestations of progressive systemic sclerosis (scleroderma)","volume":"41","author":"Baron","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/art.1780240702","article-title":"The arthropathy of advanced progressive systemic sclerosis. A radiographic survey","volume":"24","author":"Blocka","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0035","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1557988312458449","article-title":"Increased femoral cartilage thickness in patients with Klinefelter syndrome","volume":"7","author":"Inci","year":"2013","journal-title":"Am J Mens Health"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0045","first-page":"230","article-title":"Ultrasound imaging for the rheumatologist XIV. Ultrasound imaging in connective tissue diseases","volume":"26","author":"Riente","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0050","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard.2008.090738","article-title":"Ultrasound validity in the measurement of knee cartilage thickness","volume":"68","author":"Naredo","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00296-012-2462-9","article-title":"Ultrasonographic evaluation of the femoral cartilage thickness in patients with systemic lupus erythematosus","volume":"33","author":"Kaya","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.fertnstert.2011.10.024","article-title":"Ultrasonographic measurement of the femoral cartilage thickness in patients with polycystic ovary syndrome","volume":"97","author":"Eryilmaz","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0070","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0075","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0080","doi-asserted-by":"crossref","first-page":"25803","DOI":"10.1016\/S0021-9258(19)74461-5","article-title":"Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family","volume":"268","author":"Hakala","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/joca.2000.0377","article-title":"Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology","volume":"9","author":"Volck","year":"2001","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/03009749950154257","article-title":"The distribution ofYKL-40 in osteoarthritic and normal human articular cartilage","volume":"28","author":"Volck","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/030097401753180381","article-title":"Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction","volume":"30","author":"Johansen","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10067-010-1462-y","article-title":"Serum human cartilage glycoprotein-39 in patients with systemic sclerosis: relationship to skin and articular manifestation","volume":"29","author":"Wcislo-Dziadecka","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0105","first-page":"2147","article-title":"Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease","volume":"30","author":"La Montagna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0110","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/art.20365","article-title":"Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years","volume":"50","author":"Sharif","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0115","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.joca.2011.09.005","article-title":"Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis","volume":"19","author":"Hoch","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbspin.2011.02.022","article-title":"Cartilage oligomeric matrix protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap","volume":"79","author":"Gheita","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0125","first-page":"807","article-title":"Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis","volume":"70","author":"Martel-Pelletier","year":"1994","journal-title":"Lab Invest"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0130","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0135","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s10875-012-9735-7","article-title":"Matrix metalloproteinases: a review of their structure and role in systemic sclerosis","volume":"32","author":"Peng","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/rheumatology\/kei143","article-title":"Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis","volume":"45","author":"Asano","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(96)91687-6","article-title":"Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy","volume":"347","author":"Denton","year":"1996","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0150","series-title":"Knee Surg Sports Traumatol Arthrosc","article-title":"Nutrition and degeneration of articular cartilage","author":"Wang","year":"2012"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0155","first-page":"155","article-title":"Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies","volume":"14","author":"Schlaak","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0160","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de Lange-Brokaar","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0170","doi-asserted-by":"crossref","first-page":"R380","DOI":"10.1186\/ar1499","article-title":"Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and down-regulation of chondrocyte function","volume":"7","author":"Yudoh","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nm0397-276","article-title":"Scleroderma: a disease related to damaged proteins?","volume":"3","author":"Peng","year":"1997","journal-title":"Nat Med"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0180","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","article-title":"Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway","volume":"44","author":"Sambo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0185","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/rheumatology\/kel012","article-title":"Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis","volume":"45","author":"Ogawa","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0190","first-page":"137","article-title":"In vivo effect of celecoxib and tenoxicam on oxidant\/anti-oxidant status of patients with knee osteoarthritis","volume":"35","author":"Ozgocmen","year":"2005","journal-title":"Ann Clin Lab Sci"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0195","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.joca.2004.06.009","article-title":"Expression and localization of connective tissue growth factor (CTGF\/Hcs24\/CCN2) in osteoarthritic cartilage","volume":"12","author":"Omoto","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0200","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/art.21795","article-title":"Connective tissue growth factor\/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage","volume":"54","author":"Blaney Davidson","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e31829a348b_bb0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-002-0009-x","article-title":"Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis","volume":"4","author":"Leask","year":"2002","journal-title":"Curr Rheumatol Rep"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915303372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915303372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T12:55:10Z","timestamp":1646312110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915303372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0002962915303372"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31829a348b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}